Covered recipient · General Payments record
NAOMI T FEUER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,037.60
- Reported across 199 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $504.33 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $136.89 | 6 |
| ABBVIE INC. | $81.42 | 5 |
| Teva Pharmaceuticals USA, Inc. | $71.09 | 3 |
| ARGENX US, INC. | $64.52 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.82 | 2 |
| Biogen, Inc. | $25.14 | 1 |
| Grifols USA, LLC | $23.05 | 1 |
| EISAI INC. | $22.84 | 1 |
| Lundbeck LLC | $20.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.66 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103725376 | CMS |
| ABBVIE INC. | $14.13 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103725378 | CMS |
| ABBVIE INC. | $22.12 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103725380 | CMS |
| ABBVIE INC. | $13.57 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103725382 | CMS |
| ABBVIE INC. | $16.94 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103725384 | CMS |
| ARGENX US, INC. | $19.41 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142108543 | CMS |
| ARGENX US, INC. | $15.22 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142124093 | CMS |
| ARGENX US, INC. | $29.89 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142125921 | CMS |
| Biogen, Inc. | $25.14 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104829986 | CMS |
| Eisai Inc. | $22.84 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110769103 | CMS |
| Grifols USA, LLC | $23.05 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124722755 | CMS |
| Lundbeck LLC | $20.56 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145915369 | CMS |
| PFIZER INC. | $29.91 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131131565 | CMS |
| PFIZER INC. | $29.56 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131131569 | CMS |
| PFIZER INC. | $6.86 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132025763 | CMS |
| PFIZER INC. | $28.96 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131216716 | CMS |
| PFIZER INC. | $19.83 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131927790 | CMS |
| PFIZER INC. | $21.77 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131962540 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.07 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137546806 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.75 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137546810 | CMS |
| Teva Pharmaceuticals USA, Inc. | $25.26 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151588652 | CMS |
| Teva Pharmaceuticals USA, Inc. | $26.17 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151588662 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.66 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151588684 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.